Phentolamine Mesylate
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C17H19N3O · CH4O3S 377.46
Phenol, 3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-, monomethanesulfonate (salt);
m-[N-(2-Imidazolin-2-ylmethyl)-p-toluidino]phenol monomethanesulfonate (salt);
3-{[(4,5-Dihydro-1H-imidazol-2-yl)methyl](4-tolyl)amino}phenol methanesulfonate (USP 1-May-2022) CAS RN®: 65-28-1; UNII: Y7543E5K9T.
1 DEFINITION
Phentolamine Mesylate contains NLT 98.0% and NMT 102.0% of phentolamine mesylate, calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197M or 197A (USP 1-May-2022)
Change to read:
B. Spectroscopic Identification Tests 〈197〉, Ultraviolet-Visible Spectroscopy: 197U
Sample solution: 20 μg/mL of Phentolamine Mesylate (USP 1-May-2022) in water
Acceptance criteria: Meets the requirements
Change to read:
C. The retention time of the major peak of the Sample solution corresponds to that of Standard solution A, as obtained in the Assay. (USP 1-May-2022)
3 ASSAY
Change to read:
Procedure
Buffer: Transfer 10.2 g of monobasic potassium phosphate to a suitable container. Add 3000 mL of water to dissolve. Adjust with phosphoric acid to a pH of 2.5.
Solution A: Methanol and Buffer (20:80)
Solution B: Methanol and Buffer (70:30)
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 100 | 0 |
| 5.0 | 100 | 0 |
| 28.0 | 0 | 100 |
| 44.0 | 0 | 100 |
| 45 | 100 | 0 |
| 55 | 100 | 0 |
Diluent: Transfer 1.36 g of sodium acetate and 0.5 g of ethylenediamine tetraacetate disodium dihydrate to a 1000-mL volumetric flask. Add 1000 mL of water to dissolve. Adjust with glacial acetic acid to a pH of 3.8.
Standard solution A: 0.22 mg/mL of USP Phentolamine Mesylate RS in Diluent. [Note - Sonication may be needed to aid the dissolution.]
Standard solution B: 0.22 mg/mL of USP Phentolamine Related Compound A RS in Diluent. [Note - Sonication may be needed to aid the dissolution.]
Standard solution C: 0.22 mg/mL of USP Phentolamine Keto Analog RS prepared as follows. Transfer a suitable amount of USP Phentolamine Keto Analog RS to a suitable volumetric flask. Add methanol to 15% of the flask volume, and sonicate. Dilute with Diluent to volume.
System suitability solution: 0.22 mg/mL of USP Phentolamine Mesylate RS and 1.1 μg/mL each of USP Phentolamine Related Compound A RS from Standard solution B and USP Phentolamine Keto Analog RS from Standard solution C in Diluent
Sample solution: 0.22 mg/mL of Phentolamine Mesylate in Diluent
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 232 nm
Column: 4.6-mm × 15-cm; 4-μm packing L87
Flow rate: 1 mL/min
Injection volume: 10 μL
System suitability
Samples: Standard solution A and System suitability solution
[Note - The relative retention times for phentolamine keto analog, phentolamine, and phentolamine related compound A are about 0.84, 1.00, and 1.09, respectively.]
Suitability requirements
Resolution: NLT 2.0 between phentolamine and phentolamine related compound A, System suitability solution
Tailing factor: NMT 2.0, Standard solution A
Relative standard deviation: NMT 0.73%, Standard solution A
Analysis
Samples: Standard solution A and Sample solution
Calculate the percentage of phentolamine mesylate (C17H19N3O · CH4O3S) in the portion of Phentolamine Mesylate taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of phentolamine from the Sample solution
rS = peak response of phentolamine from Standard solution A
CS = concentration of USP Phentolamine Mesylate RS in Standard solution A (mg/mL)
CU = concentration of Phentolamine Mesylate in the Sample solution (mg/mL) (USP 1-May-2022)
Acceptance criteria: 98.0%–102.0% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Chloride and Sulfate 〈221〉, Sulfate
Sample: 0.10 g of Phentolamine Mesylate
Acceptance criteria: The Sample shows no more sulfate than corresponds to 0.20 mL of 0.020 N sulfuric acid (0.2%).
Change to read:
Organic Impurities
Buffer, Solution A, Solution B, Mobile phase, Diluent, Standard solution B, Standard solution C, System suitability solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay.
Sensitivity solution: 0.11 μg/mL of USP Phentolamine Mesylate RS in Diluent
Standard solution: 0.22 μg/mL of USP Phentolamine Mesylate RS and 0.33 μg/mL each of USP Phentolamine Related Compound A RS from Standard solution B and USP Phentolamine Keto Analog RS from Standard solution C in Diluent
System suitability
Samples: System suitability solution, Sensitivity solution, and Standard solution
Suitability requirements
Resolution: NLT 2.0 between phentolamine and phentolamine related compound A, System suitability solution
Relative standard deviation: NMT 5.0% for phentolamine keto analog, phentolamine, and phentolamine related compound A, Standard solution
Signal-to-noise: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of phentolamine related compound A and phentolamine keto analog in the portion of Phentolamine Mesylate taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of phentolamine related compound A or phentolamine keto analog from the Sample solution
rS = peak response of phentolamine related compound A or phentolamine keto analog from the Standard solution
CS = concentration of USP Phentolamine Related Compound A RS or USP Phentolamine Keto Analog RS in the Standard solution (μg/mL)
CU = concentration of Phentolamine Mesylate in the Sample solution (μg/mL)
Calculate the percentage of any unspecified impurity in the portion of Phentolamine Mesylate taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of any unspecified impurity from the Sample solution
rS = peak response of phentolamine from the Standard solution
CS = concentration of USP Phentolamine Mesylate RS in the Standard solution (μg/mL)
CU = concentration of Phentolamine Mesylate in the Sample solution (μg/mL)
Acceptance criteria: See Table 2. The reporting threshold is 0.05%.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
|---|---|---|
| Phentolamine keto analog | 0.84 | 0.15 |
| Phentolamine | 1.00 | – |
| Phentolamine related compound A | 1.09 | 0.15 |
| Any unspecified impurity | – | 0.10 |
| Total impurities | – | 1.0 (USP 1-May-2022) |
5 SPECIFIC TESTS
Loss on Drying 〈731〉
Analysis: Dry under vacuum at 60° for 4 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers. Store at 25°, excursions permitted, 15° - 30°.
Change to read:
USP Reference Standards 〈11〉
USP Phentolamine Keto Analog RS
N-(3-Hydroxyphenyl)-N-(4-tolyl)-4,5-dihydro-1H-imidazole-2-carboxamide.
C17H17N3O2 295.34 (USP 1-May-2022)
USP Phentolamine Mesylate RS
USP Phentolamine Related Compound A RS
N-(2-Aminoethyl)-2-[(3-hydroxyphenyl)(4-tolyl)amino]acetamide.
C17H21N3O2 299.37

